Buy NantKwest Stock | NK Stock Price & Latest News | Public
NK

NantKwest

$0.00 (0.00%)Today

    About NK

    NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headqua...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.07
    -0.14
    -0.2
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.19

    Actual EPS
    Q4 2020

    Stats

    Market Cap$999,05M
    Volume27,55k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$15.70
    1 Year Low$1.50
    Open$9.40
    High$9.66
    Low$9.17

    Buy any stock with any amount of money.

    Download the App
    Download the app